CA 15–3 Assay for the Detection of Episialin
- 1 January 1992
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- CA15-3: Its relationship to clinical stage and progression to metastatic disease in breast cancerBritish Journal of Surgery, 1989
- Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseasesBreast Cancer Research and Treatment, 1989
- Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluidsEuropean Journal of Cancer and Clinical Oncology, 1987
- The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUMNature, 1987
- Co‐expression of human cancer‐associated epitopes on mucin moleculesInternational Journal of Cancer, 1987
- Physicochemical purification and immunological characteristics of ductal carcinoma antigenInternational Journal of Cancer, 1986
- Epitopes with diagnostic and prognostic significance co-expressed on a human breast carcinoma-associated antigenEuropean Journal of Cancer and Clinical Oncology, 1986
- The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cellsEuropean Journal of Cancer and Clinical Oncology, 1985
- USE OF TWO EPITHELIUM-SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSIS OF MALIGNANCY IN SEROUS EFFUSIONSThe Lancet, 1982
- A NEW MARKER FOR HUMAN CANCER CELLS. 1. THE Ca ANTIGEN AND THE Cal ANTIBODYThe Lancet, 1982